GlassScriptPhysician profile
Irina Feldman
NPI 1417919721
$5,165.96
in general payments reported to CMS, 2019-2025
41 companies · $644 in 2025
The $644 reported for 2025 was more than what 78% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,063 · 2020: $610 · 2021: $1,183 · 2022: $528 · 2023: $716 · 2024: $421 · 2025: $644.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,782.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,782.14 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $1,878.33 | 2019-2025 | Repatha, Otezla, Repatha |
| Ibsa Pharma INC. | $439.62 | 2019-2025 | Tirosint, Licart, Licart |
| Abbvie INC. | $340.86 | 2021-2024 | |
| Vertex Pharmaceuticals Incorporated | $230.66 | 2025 | |
| Biohaven Pharmaceuticals, INC. | $217.29 | 2021 | |
| Astrazeneca Pharmaceuticals LP | $170.88 | 2019-2025 | Breztri, Farxiga, Fasenra |
| Lilly USA, LLC | $163.93 | 2019-2024 | Mounjaro |
| Radius Health, INC. | $160.57 | 2019-2025 | Tymlos |
| Intuitive Surgical, INC. | $148.95 | 2019 | |
| Merck Sharp & Dohme LLC | $139.46 | 2019-2025 | Capvaxive, Gardasil 9, Gardasil |
| Boehringer Ingelheim Pharmaceuticals, INC. | $138.15 | 2019-2022 | |
| Vertiflex, INC. | $117.66 | 2019 | |
| Eisai INC. | $96.05 | 2019-2022 | |
| Cardinal Health 200 LLC | $92.93 | 2019 | |
| Exact Sciences Corporation | $72.79 | 2023-2025 | Cologuard Collection Kit |
Show all 41 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Irina Feldman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.